WHO. Antimicrobial resistance: global report on surveillance [Internet]. www.who.int.2014. Available from: https://www.who.int/publications/i/item/9789241564748

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. https://doi.org/10.1111/j.1469-0691.2011.03570.x.

Article  CAS  PubMed  Google Scholar 

Sommer MOA, Munck C, Toft-Kehler RV, Andersson DI. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat Rev Microbiol. 2017;15(11):689–96. https://doi.org/10.1038/nrmicro.2017.75.

Article  CAS  PubMed  Google Scholar 

De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181–19. https://doi.org/10.1128/CMR.00181-19.

Article  PubMed  PubMed Central  Google Scholar 

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL, Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. https://doi.org/10.1016/S1473-3099(18)30605-4.

Article  PubMed  PubMed Central  Google Scholar 

Weist K, Högberg LD. ECDC publishes 2015 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe. Euro Surveill. 2016;21(46):30401. https://doi.org/10.2807/1560-7917.ES.2016.21.46.30399.

Article  PubMed  PubMed Central  Google Scholar 

Center for Disease Dynamics, Economics &, Policy, Washington DC. Available from: https://onehealthtrust.org/wp-content/uploads/2017/06/swa_edits_9.16.pdf

Roca A, Quintó L, Abacassamo F, Morais L, Vallès X, Espasa M, Sigaúque B, Sacarlal J, Macete E, Nhacolo A, Mandomando I, Levine MM, Alonso PL. Invasive Haemophilus influenzae disease in children less than 5 years of age in manhiça, a rural area of Southern Mozambique. Trop Med Int Health. 2008;13(6):818–26. https://doi.org/10.1111/j.1365-3156.2008.02061.x.

Article  PubMed  Google Scholar 

Khan J, Tarar SM, Gul I, Nawaz U, Arshad M. Challenges of antibiotic resistance biofilms and potential combating strategies: a review. 3 Biotech. 2021;11(4):169. https://doi.org/10.1007/s13205-021-02707-w.

Article  PubMed  PubMed Central  Google Scholar 

Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015

Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage. 2011;1(2):111–4. https://doi.org/10.4161/bact.1.2.14590.

Article  PubMed  PubMed Central  Google Scholar 

Abedon ST. Kinetics of phage-mediated biocontrol of bacteria. Foodborne Pathog Dis. 2009;6(7):807–15. https://doi.org/10.1089/fpd.2008.0242.

Article  PubMed  Google Scholar 

Al-Ishaq RK, Skariah S, Büsselberg D. Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens. Viruses. 2020;13(1):51. https://doi.org/10.3390/v13010051.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forde A, Hill C. Phages of life - the path to pharma. Br J Pharmacol. 2018;175(3):412–8. https://doi.org/10.1111/bph.14106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017;8(3):162–73. https://doi.org/10.4292/wjgpt.v8.i3.162.

Article  PubMed  PubMed Central  Google Scholar 

El Haddad L, Harb CP, Gebara MA, Stibich MA, Chemaly RF. A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans. Clin Infect Dis. 2019;69(1):167–78. https://doi.org/10.1093/cid/ciy947.

Article  CAS  PubMed  Google Scholar 

Chan BK, Turner PE, Kim S, Mojibian HR, Elefteriades JA, Narayan D. Phage treatment of an aortic graft infected with Pseudomonas aeruginosa. Evol Med Public Health. 2018;2018(1):60–6. https://doi.org/10.1093/emph/eoy005.

Article  PubMed  PubMed Central  Google Scholar 

Zalewska-Piątek B. Phage Therapy-Challenges, opportunities and future prospects. Pharmaceuticals (Basel). 2023;16(12):1638. https://doi.org/10.3390/ph16121638.

Article  CAS  PubMed  Google Scholar 

Lee JW, Chan CTY, Slomovic S, Collins JJ. Next-generation biocontainment systems for engineered organisms. Nat Chem Biol. 2018;14(6):530–7. https://doi.org/10.1038/s41589-018-0056-x.

Article  CAS  PubMed  Google Scholar 

Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis. 2019;19(1):35–45.

PubMed  Google Scholar 

Tolkunovna TS, Nishanovich FA, Kizi AK. Application of bacteriophage therapy in the treatment of children with acute tonsillitis. Int J Pediatr Adolesc Med. 2024;11(2):27–33.

Google Scholar 

McCallin S, Sarker SA, Sultana S, Oechslin F, Brüssow H. Metagenome analysis of Russian and Georgian pyophage cocktails and a placebo-controlled safety trial of single phage versus phage cocktail in healthy Staphylococcus aureus carriers. Environ Microbiol. 2018;20(9):3278–93.

CAS  PubMed  Google Scholar 

Dobretsov KG, Kolenchukova O, Sipkin A, Bellussi LM, Ciprandi G, Passali D. A randomized, double-blind, placebo-controlled study to investigate the use of bacteriophages in patients with chronic rhinosinusitis with nasal polyps. Pol J Otolaryngol. 2021;75(6):33–7.

Google Scholar 

Wright A, Hawkins CH, Änggård EE, Harper DR. A controlled clinical trial of a therapeutic bacteriophage Preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol. 2009;34(4):349–57.

CAS  PubMed  Google Scholar 

Nir-Paz R, Gelman D, Khouri A, Sisson BM, Fackler J, Alkalay-Oren S, Khalifa L, Rimon A, Yerushalmy O, Bader R, Amit S. Successful treatment of antibiotic-resistant, poly-microbial bone infection with bacteriophages and antibiotics combination. Clin Infect Dis. 2019;69(11):2015–8.

PubMed  Google Scholar 

Law N, Logan C, Yung G, Furr CL, Lehman SM, Morales S, Rosas F, Gaidamaka A, Bilinsky I, Grint P, Schooley RT. Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection. 2019;47:665–8.

PubMed  Google Scholar 

Petrovic Fabijan A, Lin RC, Ho J, Maddocks S, Ben Zakour NL, Iredell JR. Westmead bacteriophage therapy team Khalid Ali 1 3 venturini Carola 1 3 Chard Richard 3 7 Morales Sandra 8 Sandaradura Indy 2 3 Gilbey Tim 2. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat Microbiol. 2020;5(3):465–72.

CAS  PubMed  Google Scholar 

Ramirez-Sanchez C, Gonzales F, Buckley M, Biswas B, Henry M, Deschenes MV, Horne BA, Fackler J, Brownstein MJ, Schooley RT, Aslam S. Successful treatment of Staphylococcus aureus prosthetic joint infection with bacteriophage therapy. Viruses. 2021;13(6):1182.

PubMed  PubMed Central  Google Scholar 

Racenis K, Lacis J, Rezevska D, Mukane L, Vilde A, Putnins I, Djebara S, Merabishvili M, Pirnay JP, Kalnina M, Petersons A. Successful bacteriophage-antibiotic combination therapy against multidrug-resistant Pseudomonas aeruginosa left ventricular assist device driveline infection. Viruses. 2023;15(5):1210.

PubMed  PubMed Central  Google Scholar 

Gupta P, Singh HS, Shukla VK, Nath G, Bhartiya SK. Bacteriophage therapy of chronic nonhealing wound: clinical study. Int J Low Extrem Wounds. 2019;18(2):171–5.

CAS  PubMed  Google Scholar 

Teney C, Poupelin JC, Briot T, Le Bouar M, Fevre C, Brosset S, Martin O, Valour F, Roussel-Gaillard T, Leboucher G, Ader F. Phage therapy in a burn patient colonized with extensively drug-resistant Pseudomonas aeruginosa responsible for relapsing ventilator-associated pneumonia and bacteriemia. Viruses. 2024;16(7):1080.

PubMed  PubMed Central  Google Scholar 

Li L, Zhong Q, Zhao Y, Bao J, Liu B, Zhong Z, Wang J, Yang L, Zhang T, Cheng M, Wu N. First-in‐human application of double‐stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection. Microb Biotechnol. 2023;16(4):862–7.

CAS  PubMed  PubMed Central  Google Scholar 

Jennes S, Merabishvili M, Soentjens P, Pang KW, Rose T, Keersebilck E, Soete O, François PM, Teodorescu S, Verween G, Verbeken G. Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury—a case report. Crit Care. 2017;21:1–3.